Company Filing History:
Years Active: 2016-2019
Title: Doris Stingelin: Innovator in Pharmaceutical Chemistry
Introduction
Doris Stingelin is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and methods.
Latest Patents
Doris Stingelin holds 3 patents. Her latest patents include the invention of salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors. This invention relates to salts of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane, along with methods for producing these compounds, pharmaceutical compositions that include them, and their applications as medicaments.
Career Highlights
Doris is currently employed at Novartis AG, a leading global healthcare company. Her work focuses on the synthesis and application of novel pharmaceutical compounds, contributing to advancements in medical treatments.
Collaborations
Throughout her career, Doris has collaborated with notable colleagues, including Wolfgang Marterer and Mahavir Prashad. These partnerships have fostered innovation and enhanced the development of her patented technologies.
Conclusion
Doris Stingelin is a key figure in pharmaceutical innovation, with a strong portfolio of patents that reflect her expertise and dedication to improving healthcare solutions. Her contributions continue to impact the field positively.